1-7 of 7
Roland B. Walter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

Geoffrey L Uy, Vinod A Pullarkat, Praneeth Baratam, Robert K Stuart, Roland B. Walter, Eric S Winer, Qi Wang, Stefan Faderl, Divya Chakravarthy, Diane Menno, Ronald S Cheung, Tara L. Lin
Journal: Blood Advances
Blood Adv bloodadvances.2024013687.
https://doi.org/10.1182/bloodadvances.2024013687
Published: 2024
Includes: Supplemental data
Journal Articles

Measurable Residual Disease as Predictor of Post-Day +100 Relapses Following Allografting in Adult AML

Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M Sandmaier, Chris Davis, Ryan Basom, Fred R Appelbaum, Roland B. Walter
Journal: Blood Advances
Blood Adv bloodadvances.2024013214.
https://doi.org/10.1182/bloodadvances.2024013214
Published: 2024
Journal Articles

Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia (AML)

Khusboo V Pal, Megan Othus, Zahra Ali, Kathryn Russell, Carole Shaw, Mary-Elizabeth M. Percival, Paul C Hendrie, Jacob S Appelbaum, Roland B. Walter, Anna B. Halpern
Journal: Blood Advances
Blood Adv bloodadvances.2024014291.
https://doi.org/10.1182/bloodadvances.2024014291
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

Clinical Trials & Observations
Anna B. Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A. Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Siobán B. Keel, Paul C. Hendrie, Bart L. Scott, M. Cristina Ghiuzeli, Elihu H. Estey, Roland B. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4950–4961.
https://doi.org/10.1182/bloodadvances.2023010392
Published: 2023
Journal Articles

Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms

Clinical Trials & Observations
Julian Lindsay, Carla S. Walti, Anna B. Halpern, Hu Xie, E. Lisa Chung, Kelda G. Schonhoff, Emily M. Huebner, Guang-Shing Cheng, Louise E. Kimball, Wendy M. Leisenring, Matthew Greenwood, Sharon C. -A. Chen, David C. M. Kong, Monica A. Slavin, Michael Boeckh, David N. Fredricks, Catherine Liu, Steven A. Pergam, Roland B. Walter, Joshua A. Hill
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3140–3145.
https://doi.org/10.1182/bloodadvances.2022009562
Published: 2023
Includes: Supplemental data
Journal Articles

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Clinical Trials & Observations
Frances Linzee Mabrey, Kelda M. Gardner, Kathleen Shannon Dorcy, Andrea Perdue, Heather A. Smith, Alicyn M. Davis, Cody Hammer, Donelle Rizzuto, Sunny Jones, Kim Quach, Bart L. Scott, Paul C. Hendrie, Mary-Elizabeth M. Percival, Roland B. Walter, Frederick R. Appelbaum, Elihu H. Estey, Pamela S. Becker
Journal: Blood Advances
Blood Adv (2020) 4 (4): 611–616.
https://doi.org/10.1182/bloodadvances.2019000707
Published: 2020
Includes: Supplemental data
Journal Articles

Evaluating measurable residual disease in acute myeloid leukemia

Clinical Trials & Observations
Farhad Ravandi, Roland B. Walter, Sylvie D. Freeman
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1356–1366.
https://doi.org/10.1182/bloodadvances.2018016378
Published: 2018